Stock Update: Arrowhead Research Corp (NASDAQ:ARWR) Issues Letter to Shareholders
Arrowhead Research Corp (NASDAQ:ARWR),a biopharmaceutical company developing targeted RNAi therapeutics, today issued an open letter to shareholders from President and CEO, Christopher...